Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Humpolec

5 clinical trials in Humpolec, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Humpolec at a glance
5
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Humpolec

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ezetimibe
  • Sponsor:NewAmsterdam Pharma B.V.
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Humpolec

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical research focusing on heart failure prevention and cardiovascular health management. The trials explore combination therapies aimed at reducing cardiovascular mortality risks.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • Combination Therapy Assessment

These studies evaluate the effectiveness of novel therapeutic combinations in participants who are at elevated risk of developing cardiovascular complications, with a particular focus on preventing heart failure events.

02 Preventive Medicine

Advanced research investigating preventive strategies for high-risk cardiovascular patients. The studies focus on proactive intervention approaches using combination drug therapies.

  • Risk Factor Modification
  • Early Intervention Strategies
  • Preventive Care Optimization

This research aims to establish new standards in preventive cardiology by evaluating innovative therapeutic approaches for patients at risk of cardiac events.

03 Clinical Outcomes

Comprehensive evaluation of cardiovascular outcomes in clinical trials testing new combination treatments. The research specifically targets reduction in heart failure incidents and cardiovascular mortality.

  • Mortality Risk Reduction
  • Treatment Efficacy Assessment
  • Patient Outcome Improvement

These trials are designed to measure the impact of innovative therapeutic combinations on long-term cardiovascular health outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.